News & Events

Stay up to date with all the latest news & events from Cardiologs.

November 22, 2021
Cardiologs’ AI Receives 510(k) Clearance for Pediatric Use

New data shows improved deep learning algorithm performs equally across all age groups, enabling more patients to benefit from the company’s cardiac diagnostics AI platform...

Read More
November 16, 2021
New Study Shows Cardiologs’ Deep Learning AI Outperforms the Apple Watch ECG Algorithm in Detecting Atrial Arrhythmias

Clinical data presented at the American Heart Association Scientific Sessions 2021 PARIS and Boston, Mass. – November 16, 2021 – Cardiologs, a global leader in...

Read More
September 16, 2021
Cardiologs’ AI improves services for Cardiologists at three European medical centers

PARIS and BOSTON, Sept. 16, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, is collaborating with cardiologists at three medical centers in France to strengthen their cardiology...

Read More
September 13, 2021
Cardioréliance – Centre Cardiologique d’Orléans – Pôle Santé Oréliance, réduit drastiquement les délais de diagnostic des troubles du rythme cardiaque

PARIS, 13 septembre 2021 — Avec le déploiement de la solution de Cardiologs, entreprise française leader mondial du diagnostic électrocardiogramme (ECG) basé sur l’intelligence artificielle,...

Read More
July 21, 2021
Cardiologs Unveils New Solution to Enable Use of Smartwatches for Remote Patient Monitoring

PARIS and BOSTON, July 21, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced the launch of Cardiologs RPM – an innovative new solution that...

Read More
February 10, 2021
New Study Published in JACC Clinical EP Validates that Cardiologs’ AI Eliminates Nearly Two-Thirds of False Positives in Remote Monitoring for AFib

PARIS and BOSTON, Feb. 10, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced that results of a clinical study the company conducted in...

Read More